Imatron wins clearance for angiographic EBT

Article

Ultrafast CT developer Imatron won a victory this month when it received Food and Drug Administration clearance to use its electron beam tomography (EBT) scanner for angiographic applications. With the clearance, South San Francisco, CA-based Imatron can

Ultrafast CT developer Imatron won a victory this month when it received Food and Drug Administration clearance to use its electron beam tomography (EBT) scanner for angiographic applications. With the clearance, South San Francisco, CA-based Imatron can perform electron beam angiography (EBA) of the coronary arteries, a procedure unique to EBT and feasible because of the unit’s scan speed, according to the company.

For angiography, the company’s EBT scanner functions as a diagnostic x-ray system that produces 2-D and 3-D images of the heart, blood vessels, and lymphatic system from a set of cross-sectional anatomical images. EBT can also display 3-D images of the heart in cine mode in its angiography capacity. Imatron estimates that the scanner could eliminate the need for roughly 20% to 40% of conventional coronary angiogram procedures each year.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.